Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2025-12-30 @ 3:10 AM
Study NCT ID:
NCT06743503
Status:
RECRUITING
Last Update Posted:
2025-09-18
First Post:
2024-12-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies
Sponsor:
Nanjing IASO Biotechnology Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
UB-VV400CI001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |